The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
127996421 12799642 1 I 20160727 20160923 20160930 20160930 EXP GB-MHRA-TPP24080327C1860021YC1469606037611 GB-MYLANLABS-2016M1041280 MYLAN 0.00 Y 0.00000 20160930 MD GB GB

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
127996421 12799642 1 PS INDAPAMIDE. INDAPAMIDE 1 Oral 2.5 MG, UNK Y U 74461 2.5 MG
127996421 12799642 2 C AMITRIPTYLINE HYDROCHLORIDE. AMITRIPTYLINE HYDROCHLORIDE 1 50 MG, QD (AT NIGHT.) 1800 MG U 0 50 MG QD
127996421 12799642 3 C AMLODIPINE AMLODIPINE BESYLATE 1 1 DF, QD 41 DF U 0 1 DF QD
127996421 12799642 4 C ATORVASTATIN ATORVASTATIN 1 1 DF, QD (AT NIGHT) 36 DF U 0 1 DF QD
127996421 12799642 5 C DOCUSATE SODIUM. DOCUSATE SODIUM 1 2 DF, UNK (TWICE DAILY.) U 0 2 DF TABLET
127996421 12799642 6 C FERROUS SULFATE. FERROUS SULFATE 1 1 DF, QD 36 DF U 0 1 DF QD
127996421 12799642 7 C FLUTICASONE FLUTICASONEFLUTICASONE PROPIONATE 1 Respiratory (inhalation) 2 DF, BID 144 DF U 0 2 DF BID
127996421 12799642 8 C LACTULOSE. LACTULOSE 1 15 ML, UNK (TWICE DAILY.) U 0 15 ML
127996421 12799642 9 C LEVOTHYROXINE. LEVOTHYROXINE 1 100 ?G, QD (EACH MORNING.) 3600 UG U 0 100 UG QD
127996421 12799642 10 C PARACETAMOL ACETAMINOPHEN 1 TAKE 1 OR 2, 4 TIMES A DAY. U 0 TABLET
127996421 12799642 11 C PREGABALIN. PREGABALIN 1 250 MG, BID (100 MG IN THE MORNING AND 150 MG AT NIGHT) 18000 MG U 0 250 MG BID
127996421 12799642 12 C RAMIPRIL. RAMIPRIL 1 10 MG, QD (IN THE EVENING) 360 MG U 0 10 MG QD
127996421 12799642 13 C SALBUTAMOL ALBUTEROL 1 Respiratory (inhalation) 2 DF, UNK U 0 2 DF
127996421 12799642 14 C SERETIDE FLUTICASONE PROPIONATESALMETEROL XINAFOATE 1 Respiratory (inhalation) UNK U 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
127996421 12799642 5 Constipation

Outcome of event

Event ID CASEID OUTC COD
127996421 12799642 OT
127996421 12799642 LT
127996421 12799642 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
127996421 12799642 Confusional state
127996421 12799642 Hyponatraemia

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
127996421 12799642 1 20160727 0
127996421 12799642 2 20160621 0
127996421 12799642 3 20160616 0
127996421 12799642 4 20160621 0
127996421 12799642 5 20160621 0
127996421 12799642 6 20160621 0
127996421 12799642 7 20160621 0
127996421 12799642 8 20160621 0
127996421 12799642 9 20160621 0
127996421 12799642 10 20160621 0
127996421 12799642 11 20160621 0
127996421 12799642 12 20160621 0
127996421 12799642 13 20160621 0